SecBot SecBot
PRESS-RELEASE ·Filed Apr 1, 2026

SYK

Stryker Corporation
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

Traders should prepare for the earnings release and webcast on April 30, 2026. Monitor for revenue growth trends, EPS performance, and any changes to full-year guidance, especially given Stryker's large market cap and high analyst coverage.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$329.40
T+0 close · Apr 1, 2026 · via day close
Latest settled
+1.01%
T+60 · $332.71
Vs SPY
−10.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 1 $329.40entry
  2. T+1 · 8mo ago +0.58%α +0.50% · $331.31
  3. T+5 · 7mo ago +2.78%α −0.98% · $338.56
  4. T+20 · 7mo ago −4.33%α −14.05% · $315.13
  5. T+60 · 5mo ago +1.01%α −10.25% · $332.71
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Stryker announced it will release its Q1 2026 financial results on April 30, 2026, followed by a webcast discussion. This is a routine earnings announcement with no financial data disclosed yet.

Key Facts

  • Stryker will report Q1 2026 earnings on April 30, 2026, after market close.
  • Press release with summary financials will be issued at approximately 4:05 p.m. ET.
  • Webcast to discuss results will begin at 4:30 p.m. ET and be available via Stryker's investor relations website.
  • No financial results or guidance updates were included in this announcement.

Financial Impact

Awaiting actual financial results; no impact can be assessed at this time.

revenueepsguidance

Risk Factors

  • Earnings could miss consensus expectations despite positive sentiment among analysts.
  • Management may provide cautious guidance due to macroeconomic or regulatory headwinds in medical devices.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
76% bullish (37 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3266530

Track record

29 reports on SYK

Performance horizon

5 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +23.40% at T+20 after the Oct 7, 2026 report. 7 of 11 went positive at some point.

Filters
  1. Nov 12, 20266d ago Court Ruling Neutral 3/10 Entry $309.64 Now $310.72 +0.35% settles Dec 14
  2. Nov 9, 20268d ago 8-K Neutral 2/10 Entry $324.29 Now $310.72 −4.18% settles Dec 9
  3. Nov 5, 202612d ago 144 Neutral 3/10 Entry $325.87 Now $310.72 −4.65% settles Dec 7
  4. Nov 4, 202613d ago S-3ASR Neutral 3/10 Entry $335.08 Now $310.72 −7.27% settles Dec 4
  5. Nov 3, 202614d ago Institutional Cluster Mixed 3/10 Entry $310.55 Now $310.72 +0.05% settles Dec 2
  6. Oct 29, 202619d ago 8-K Bearish 6/10 No price data
  7. Oct 29, 202619d ago Press Release Bearish 6/10 Entry $291.86 Now $310.72 −6.46% settles Nov 30
  8. Oct 26, 202622d ago Press Release Neutral 4/10 Entry $306.13 Now $310.72 +1.50% settles Nov 23
  9. Oct 20, 202629d ago PTAB Trial Bearish 5/10 Entry $297.60 Now $310.72 −4.41% settles Nov 18
  10. Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $275.25 to $339.65 Now $310.72 +12.89% ▲ +23.40% +24.74% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Thu (12h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026